He, P., Lian, W., Ding, X., Fan, X., Ma, C., Ye, Y., Fu, P., Zhang, D., Ding, X., & Lin, G. (2020). Lung injury induced by pyrrolizidine alkaloids depends on metabolism by hepatic cytochrome P450s and blood transport of reactive metabolites.

Arenas, A., Chen, Q., Kuang, L., Barnett, K., Kasarskis, E., Gal, J., & Zhu, Z. (2020). Lysine acetylation regulates the RNA binding, subcellular localization and inclusion formation of FUS. 29(16). https://doi.org/10.1093/hmg/ddaa159

Mashaqi, S., Mansour, H., Alameddin, H., Combs, D., Patel, P., Estep, L., & Parthasarathy, G. (2020). Matrix metalloproteinase-9 as a messenger in the crosstalk between obstructive sleep apnea and comorbid systemic hypertension, cardiac remodeling, and ischemic stroke: a literature review. https://doi.org/10.5664/jcsm.8928

Butler, D., Boucher, E., Tobison, J., & Phan, H. (2020). Medication Use in Schools: Current Trends, Challenges, and Best Practices. 25(1). https://doi.org/10.5863/1551-6776-25.1.7

Li, X., Lang, Y., Sakamuru, S., Samrat, S., Trudeau, N., Kuo, L., Rugenstein, N., Tharappel, A., D’Brant, L., Koetzner, C., Hu, S., Zhang, D., Huang, P.-L., Kramer, S., Butler, D., Xia, M., & Li, X. (2020). Methylene blue is a potent and broad-spectrum inhibitor against Zika virus in vitro and in vivo. 9(1).

Alamer, A., & Abraham, I. (2020). Mortality in COVID-19 patients treated with ACEIs/ARBs: Re-estimated meta-analysis results following the Mehra et al. retraction. 160. https://doi.org/10.1016/j.phrs.2020.105053

Harland, M., Torres, S., Liu, P., & Wang, L. (2020). Neuronal Mitochondria Modulation of LPS-Induced Neuroinflammation. 40(8). https://doi.org/10.1523/JNEUROSCI.2324-19.2020

Gaffney, D., Jennings, E., Anderson, E., Marentette, J., Shi, C., Oxvig, A., Streeter, M., Johannsen, M., Spiegel, D., Chapman, E., Roede, J., & Galligan, J. (2020). Non-enzymatic Lysine Lactoylation of Glycolytic Enzymes.

Liu, P., Dodson, M., Fang, D., Chapman, E., & Zhang, D. (2020). NRF2 negatively regulates primary ciliogenesis and hedgehog signaling. 18(2). https://doi.org/10.1371/journal.pbio.3000620

Combs, D., Edgin, J., Klewer, S., Barber, B., Morgan, W., Hsu, C., Abraham, I., & Parthasarathy, G. (2020). OSA and Neurocognitive Impairment in Children With Congenital Heart Disease. 158(3). https://doi.org/10.1016/j.chest.2020.03.021

Guerra, B., Vaffis, S., Axon, D., Leal, S., Warholak, T., Taylor, A., & Scovis, N. (2020). Perceptions and experiences of promotoras and pharmacists in an academic-community partnership providing telephonic MTM services to a Spanish-speaking, rural population: a focus group study. 26(11). https://doi.org/10.18553/jmcp.2020.26.11.1390

Tompkinson, M., Fine, K., Gruber, D., Abraham, I., & McBride, A. (2020). Perceptions of Health-Care Workers of the Cost and Safety of Oral Oncolytic Agents for Patients: A Survey. 11(4). https://doi.org/10.6004/jadpro.2020.11.4.3

Yadavalli, T., Mallick, S., Patel, P., Koganti, R., Shukla, D., & Date, A. (2020). Pharmaceutically Acceptable Carboxylic Acid-Terminated Polymers Show Activity and Selectivity against HSV-1 and HSV-2 and Synergy with Antiviral Drugs.

Lott, B., Anderson, E., Zapata, L., Cooley, J., Forbes, S., Taylor, A., & Warholak, T. (2020). Pharmacists’ perceptions of the pharmacists’ patient care process and performance in a simulated patient interaction. 60(6). https://doi.org/10.1016/j.japh.2020.03.017

R.Axon, D., Aljadeed, R., Potisarach, P., Forbes, S., DiLeo, J., & Warholak, T. (2020). Pilot study of focus groups exploring student pharmacists’ perceptions of a medication management center internship. 12(9).

Almutairi, A., McBride, A., Slack, M., Erstad, B., & Abraham, I. (2020). Potential Immune-Related Adverse Events Associated With Monotherapy and Combination Therapy of Ipilimumab, Nivolumab, and Pembrolizumab for Advanced Melanoma: A Systematic Review and Meta-Analysis. 10. https://doi.org/10.3389/fonc.2020.00091

Bingham, J., Taylor, A., Boesen, K., & Axon, D. (2020). Preliminary Investigation of Pharmacist-Delivered, Direct-to-Provider Interventions to Reduce Co-Prescribing of Opioids and Benzodiazepines among a Medicare Population. 8(1). https://doi.org/10.3390/pharmacy8010025

Alkhatib, N., McBride, A., Slack, M., Bhattacharjee, S., Erstad, B., Ramos, K., & Abraham, I. (2020). Pricing methods in outcome-based contracting: integration analysis of the six dimensions (6 δs). 23(11). https://doi.org/10.1080/13696998.2020.1815031

Alkhatib, N., Ramos, K., Erstad, B., Slack, M., McBride, A., Bhattacharjee, S., & Abraham, I. (2020). Pricing methods in outcome-based contracting: δ1: cost effectiveness analysis and cost-utility analysis-based pricing. 23(11). https://doi.org/10.1080/13696998.2020.1815025

Alkhatib, N., Ramos, K., Erstad, B., Slack, M., McBride, A., Bhattacharjee, S., & Abraham, I. (2020). Pricing methods in outcome-based contracting: δ2: willingness-to-pay-based pricing. 23(11). https://doi.org/10.1080/13696998.2020.1815026

Alkhatib, N., Erstad, B., Ramos, K., McBride, A., Bhattacharjee, S., Slack, M., & Abraham, I. (2020). Pricing methods in outcome-based contracting: δ3: reference-based pricing. 23(11). https://doi.org/10.1080/13696998.2020.1815027

Alkhatib, N., Bhattacharjee, S., McBride, A., Ramos, K., Slack, M., Erstad, B., & Abraham, I. (2020). Pricing methods in outcome-based contracting: δ4: safety-based pricing. 23(11). https://doi.org/10.1080/13696998.2020.1815028

Alkhatib, N., McBride, A., Bhattacharjee, S., Ramos, K., Erstad, B., Slack, M., Billheimer, D., & Abraham, I. (2020). Pricing methods in outcome-based contracting: δ5: risk of efficacy failure-based pricing. 23(11). https://doi.org/10.1080/13696998.2020.1815029

Alkhatib, N., Slack, M., Bhattacharjee, S., Erstad, B., Ramos, K., McBride, A., & Abraham, I. (2020). Pricing methods in outcome-based contracting: δ6: adherence-based pricing. 23(11). https://doi.org/10.1080/13696998.2020.1815030

Ding, X., Li, X., Liu, P., Bao, X., Dickman, K., Sell, S., Mei, C., Zhang, D., Gu, J., & Ding, X. (2020). Proximal Tubular Vacuolization and Hypersensitivity to Drug-Induced Nephrotoxicity in Male Mice With Decreased Expression of the NADPH-Cytochrome P450 Reductase. 173(2). https://doi.org/10.1093/toxsci/kfz225

Vadiei, N., Howe, C., Zerr, B., Ladziak, N., Fain, M., & Lee, J. (2020). Psychotropic medication use patterns in home-based primary care: A scoping review. 10(5). https://doi.org/10.9740/mhc.2020.09.282

Van Aken, E., Favreau, M., Ramboer, E., Denhaerynck, K., Macdonald, K., Abraham, I., & Brié, H. (2020). Real-World Outcomes in Patients with Diabetic Macular Edema Treated Long Term with Ranibizumab (VISION Study). 14. https://doi.org/10.2147/OPTH.S281501

Oh, M., McBride, A., Yun, S., Bhattacharjee, S., Slack, M., Martin, J., Jeter, J., & Abraham, I. (2020). Response to Yang, Shi, Wang et al. 112(4). https://doi.org/10.1093/jnci/djz163

Perales, I., San Agustin, K., DeAngelo, J., & Campbell, P. (2020). Rivaroxaban Versus Warfarin for Stroke Prevention and Venous Thromboembolism Treatment in Extreme Obesity and High Body Weight. 54(4). https://doi.org/10.1177/1060028019886092

Lyu, Q., Wang, L., Kang, Y., Wu, C., Zheng, Q., Laprocina, K., Junghans, K., Ding, X., & Huang, P.-L. (2020). RNA-Seq Reveals Sub-Zones in Mouse Adrenal Zona Fasciculata and the Sexually Dimorphic Responses to Thyroid Hormone. 161(9). https://doi.org/10.1210/endocr/bqaa126